Effects of Guben Zenggu Decoction on Bone Metabolism and Bone Microstructure in Ovariectomized Rats

DONG Wan-tao, GONG Yan-long, SONG Min, HUANG Kai, DONG Ping, SONG ZHI-jing, WANG Kai, HAI YUN-xiang

Abstract

To test the effects of Guben Zenggu Decoction on bone metabolism and bone microstructure in ovariectomized rats for the purpose of preventing and treating postmenopausal osteoporosis.  Methods   Osteoporosis rat models were established by ovariectomy. The model rats were randomly divided into control, estradiol valerate treatment, and Guben Zenggu Decoction treatment groups with high, medium and low dosages. After 12 weeks of treatments, 10 rats from each group were randomly selected for cardiac blood sampling after abdominal anesthesia. The serum levels of estradiol (E2), osteocalcin (BGP), carboxyterminal of type Ⅰ procollagen (PICP), collagen type Ⅰ pyridine crosslinking peptide (ICTP) and acid tartaric acid phosphatase-5b (TRAP-5b) were determined by ELISA. Bone histomorphometric analysis was performed on the right femoral specimen of rats using micro-CT imaging.  Results   The models rats had lower levels of E2, bone alkaline phosphatase (BALP) and relative bone volume fraction (BV/TV), trabecular thickness (Tb.Th), number of trabeculae (Tb.N) and connectivity density (Conn.D), and higher levels of BGP, ICTP, PICP, TRAP-5b and degree of trabecular separation (Tb.Sp), structural model index (SMI) than their normal counterparts (P < 0.05). Estradiol valerate and Guben Zenggu Decoction treatments increased the levels of E2, BALP, BV/TV, Tb.Th, Tb.N, and Conn.D significantly (P < 0.05). Higher doses of Guben Zenggu Decoction resulted in higher changes (P < 0.05).  Conclusion   Guben Zenggu Decoction can improve bone metabolism and bone micro-structure in ovariectomized rats, thus playing a preventive and therapeutic role in postmenopausal osteoporosis.

 

Keywords: Postmenopausal osteoporosis, Guben Zenggu Decoction, Bone metabolic markers, Bone microstructures

 

Full Text:

PDF


References


MOREIRA L D.OLIVEIRA M L, LIRANI-GALVAO A P. et al. Physical exercise and osteoporosis: effects of different types of exercises on hone and physical function of postmenopausal women. Arq Bras Endocrinol Metabol, 2014. 58(5);514-522.

LAMBERT М N Т, THYBO С В. LYKKEBOE S, et al. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women;a randomized controlled trial. Am J Clin Nut r.2017.106(3):909-920.

BACCARO L F.CONDE D MXOSTA-PAIVA L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging. 2015,10(5):583-591.

BARNUEVO M D. MARHUENDA J, ALDEGUER M. et al. In vivo randomized trial of three marketed milk preparations enriched with calcium and vitamins (I) and К) on bone mass and hone turnover markers from biological fluids in premenopausal Caucasian women. Nutr Hosp.2018, 35(5):1174-1185.

CAVALIER E.BERGMANN P, BRUYeRE O, et al. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease; a consensus paper of the Belgian Bone Club. Osteoporos Int,2016,27(7);2181-2195.

TAKIMOTO T, HATANAKA M, HOSHINO T. et al. Effect of Bacillus sublilis C-3102 on bone mineral density in healthy postmenopausal Japanese women; a randomized, placebo-controlled, double-blind clinical trial. Biosci Microbiota Food Health.2018,37(8);87-96.

RAN S Y. YU Q. CHEN Y. et al. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study. Climacteric,2017,20(4): 391-396.

COELINGH BENNINK H J T, VERHOEVEN C. ZIMMERMAN Y. et al. Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study. Menopause, 2017 , 24 ( 6 ): 677-685.

KAMPSCHULTE M, LANGHEINIRCH A C, SENDER J, et al. Nano-computed tomography: technique and applications. Rofo,2016,188( 2): 146-154.


Refbacks

  • There are currently no refbacks.